This is a program of the U.S. Department of Health and Human Services, Office of Public Health Emergency Medical Countermeasures, and the National Institutes of Health. The program is coordinated by NIAID, with the involvement of the National Cancer Institute.
NIAID’s Radiation and Nuclear Countermeasures Program (RNCP) gets approval for new Research Initiative Concepts at May, 2015 Council Meeting.
Solicitation: NNH15ZSA002L: NASA and NSBRI Request for Information (RFI) on Topics Supporting Crew Health and Performance. Topic # 19: Protecting Healthy-Tissues from Ionizing Radiation: Testing Potential Countermeasures in Human Clinical Research Trials. Due Date June 19, 2015.
Media Availability: NIH-Funded Research Leads to Approval of Drug for Acute Radiation Injury—April 21, 2015
FDA approves Neupogen® for treatment of patients with radiation-induced myelosuppression following a radiological/nuclear incident
All Radiological and Nuclear Threats News Releases
News From NIAID-Supported Institutions
Last Updated June 15, 2015